Publications by authors named "C Di Bartolo"
Background: Limited data exist regarding outcomes of cryptococcosis in patients without HIV with few studies having compared outcomes of Cryptococcus gattii, versus C. neoformans, infection.
Methods: We conducted a retrospective study in 46 Australian and New Zealand hospitals to determine the outcomes of cryptococcosis in patients without HIV diagnosed between 2015 and 2019, and compared outcomes of C.
Objectives: The objectives of this study are as follows: to assess the uropathogen antibiogram at two tertiary hospitals in Victoria to look at the difference in susceptibility patterns, to assess whether national guideline recommendations were applicable and to assess the feasibility of local antibiogram analysis to guide development of hospital-specific guidelines for empirical treatment of urosepsis and for pre-operative prophylaxis for urological procedures.
Patients And Methods: All positive urine cultures analysed at Barwon Health and Monash Health, two tertiary hospitals in regional and metropolitan Victoria, Australia, respectively, between January 2019 and December 2020 were retrospectively identified. Data obtained included the organism cultured and their susceptibility profiles.
Article Synopsis
- The study investigates the risk of patients with severe COVID-19 acquiring resistance genes from carbapenemase-producing Enterobacterales (CPE) in an intensive care setting.
- Conducted at a tertiary public hospital in Victoria, Australia, the analysis examined cases of three patients who shared room spaces and were on prolonged mechanical ventilation and broad-spectrum antibiotics, leading to the suspicion of gene transmission.
- Despite screening 34 patients, no new CPE cases emerged, indicating independent gene acquisition rather than transmission; findings underscore the need for improved antimicrobial stewardship and infection prevention to combat CPE resistance.
Article Synopsis
- The study examines how the Barwon South-West Public Health Unit managed COVID-19 cases during 2020, focusing on their operational model and the impact of community transmission.
- Between March and October 2020, 575 confirmed cases were reported in the region, with a 4.7% hospitalization rate and a 1.7% fatality rate, particularly during a major outbreak in Wave 2.
- The local interprofessional model of care was effective in controlling outbreaks, leading to the elimination of the virus within three months and offering valuable insights for future public health strategies in Victoria.
Objectives: Estimates of secondary infections are variedly reported, with few studies done in Australia. We investigated the occurrence and impact of secondary infections complicating COVID-19 and post-COVID-19 admissions in Victoria, Australia, 2020-2023.
Methods: We used linked population-wide data sets and specific International Classification of Disease, 10th Revision codes to identify and estimate the occurrence of secondary infections.